GATA1 mutations are always present in ML-DS blasts and, where available, targeted or genome-wide next-generation sequencing usually reveals mutations in additional known oncogenes, such as the cohesin genes, as described above [12••, 13]. The gene discussed is GATA1; the disease is Dravet syndrome.